These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28122960)

  • 21. Role of Ondansetron in Reducing Methotrexate Intolerance in Patients with Inflammatory Arthritis.
    Saif S; Kakalia S; Kitchlew R; Khan HA; Fida S; Siddique M
    J Coll Physicians Surg Pak; 2022 Oct; 32(10):1308-1312. PubMed ID: 36205276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing methotrexate intolerance and its prevalence in rheumatoid arthritis: Development and validation of the MISA questionnaire.
    Vijaykumar D; Dhir V; Jain S; Pai V; Kaur J; Naidu GS; Sharma A; Khanna Sharma S; Jain S
    Int J Rheum Dis; 2021 Oct; 24(10):1294-1301. PubMed ID: 34432365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MISS questionnaire in French version: a good tool for children and parents to assess methotrexate intolerance.
    Chausset A; Fargeix T; Pereira B; Echaubard S; Duquesne A; Desjonquères M; Freychet C; Belot A; Merlin E
    Clin Rheumatol; 2017 Jun; 36(6):1281-1288. PubMed ID: 28477218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score.
    Bulatović M; Heijstek MW; Verkaaik M; van Dijkhuizen EH; Armbrust W; Hoppenreijs EP; Kamphuis S; Kuis W; Egberts TC; Sinnema G; Rademaker CM; Wulffraat NM
    Arthritis Rheum; 2011 Jul; 63(7):2007-13. PubMed ID: 21437879
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Roszkiewicz J; Michałek D; Ryk A; Swacha Z; Szmyd B; Smolewska E
    Scand J Rheumatol; 2021 May; 50(3):213-217. PubMed ID: 33025831
    [No Abstract]   [Full Text] [Related]  

  • 26. Methotrexate Hepatotoxicity in Children with Juvenile Idiopathic Arthritis: A Single-Center Study.
    Yassin NA; Haroon M; Elhamshary A
    Curr Rheumatol Rev; 2021; 17(2):242-246. PubMed ID: 33308133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
    Funk RS; Chan MA; Becker ML
    Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis.
    Falvey S; Shipman L; Ilowite N; Beukelman T
    Pediatr Rheumatol Online J; 2017 Jun; 15(1):52. PubMed ID: 28629458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry.
    Foeldvari I; Becker I; Horneff G
    Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1529-35. PubMed ID: 25988824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
    Klotsche J; Niewerth M; Haas JP; Huppertz HI; Zink A; Horneff G; Minden K
    Ann Rheum Dis; 2016 May; 75(5):855-61. PubMed ID: 25926155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA.
    Klotsche J; Minden K; Niewerth M; Horneff G
    Ann Rheum Dis; 2018 Jul; 77(7):996-1002. PubMed ID: 29453217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance.
    Smits RM; Veldhuijzen DS; van Middendorp H; Hissink Muller PCE; Armbrust W; Legger E; Wulffraat NM; Evers AWM
    Pediatr Rheumatol Online J; 2020 Feb; 18(1):12. PubMed ID: 32033577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of methotrexate in children with rheumatic diseases.
    Gutiérrez-Suárez R; Burgos-Vargas R
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world data on MTX tolerance with regimens used in children versus adults.
    Kaya Akca U; Farisogullari B; Yardimci GK; Sag E; Atalay E; Kasap Cuceoglu M; Basaran O; Kilic L; Ozen S; Bilginer Y
    Clin Rheumatol; 2021 Dec; 40(12):5095-5102. PubMed ID: 34218394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy.
    Lahdenne P; Rapola J; Ylijoki H; Haapasaari J
    J Rheumatol; 2002 Nov; 29(11):2442-5. PubMed ID: 12415606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-Cultural Adaptation and Validation of the Methotrexate Intolerance Severity Score Questionnaire in Portuguese (Brazil) for Children and Adolescents with Juvenile Idiopathic Arthritis.
    Londe AC; de Amorim JC; Julio PR; Wulffraat NM; Marini R; Appenzeller S
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
    Chickermane PR; Khubchandani RP
    Clin Exp Rheumatol; 2015; 33(2):287-92. PubMed ID: 25738527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
    Alsufyani K; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Malleson PN
    J Rheumatol; 2004 Jan; 31(1):179-82. PubMed ID: 14705239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: a retrospective study.
    Leiskau C; Thon A; Gappa M; Dressler F
    Clin Exp Rheumatol; 2012; 30(2):302-7. PubMed ID: 22409955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
    Hissink Muller PC; Brinkman DM; Schonenberg D; Koopman-Keemink Y; Brederije IC; Bekkering WP; Kuijpers TW; van Rossum MA; van Suijlekom-Smit LW; van den Berg JM; Allaart CF; Ten Cate R
    Pediatr Rheumatol Online J; 2017 Feb; 15(1):11. PubMed ID: 28166785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.